Nallicheri Melanie 4
4 · Foundation Medicine, Inc. · Filed Jul 5, 2018
Insider Transaction Report
Form 4
Nallicheri Melanie
Chief Business Officer
Transactions
- Sale
Common Stock
2018-07-02$136.66/sh−2,008$274,413→ 66,011 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
- [F2]The reporting person previously reported the restricted stock units granted to the reporting person on (1) October 1, 2016 in Table I of the Form 3 filed on July 5, 2017 and (2) April 1, 2018 in Table I of the Form 4 filed on April 3, 2018. As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting events related to this securities sale.